Andrew D Dickinson sold $13.8M of Gilead Sciences (GILD)

Executed Jan 31 2025, disclosed Feb 3 2025, 3 days later.

Value, as filed

$13.8M

142,180 sh × $97.22

Executed

Jan 31 2025

the trade date, as filed

Disclosed

Feb 3 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Andrew D Dickinson Chief Financial Officer profile →

Andrew D Dickinson (Chief Financial Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $469K of GILD (3,000 sh × $156.22, as filed), executed Oct 15.

The name

GILD

Gilead Sciences, Inc. GILD · Healthcare · 88 filings in 24 months ticker →

Healthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Andrew D Dickinson in GILD

GILDSALE Gilead Sciences, Inc. $469K
3,000 sh × $156.22
Exec Oct 15
Filed Oct 16 · 4:17 PM ET GILDSALE Gilead Sciences, Inc. $415K
3,000 sh × $138.36
Exec Aug 17
Filed Aug 18 · 7:06 PM ET GILDSALE Gilead Sciences, Inc. $390K
3,000 sh × $129.93
Exec Jul 15
Filed Jul 16 · 6:08 PM ET GILDSALE Gilead Sciences, Inc. $376K
3,000 sh × $125.40
Exec Jun 15
Filed Jun 16 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $397K
3,000 sh × $132.27
Exec May 15
Filed May 18 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $423K
3,000 sh × $140.96
Exec Apr 15
Filed Apr 16 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $433K
3,000 sh × $144.23
Exec Mar 16
Filed Mar 17 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $463K
3,000 sh × $154.43
Exec Feb 17
Filed Feb 18 · 5:30 PM ET